Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1486.494
  • -1.903-0.13%
Trading Oct 15 15:38 ET
1498.909High1483.872Low
Constituent Stocks: 10Top Rising: SGMO+6.80%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
SGMOSangamo Therapeutics
0.9910.063+6.83%3.58M3.41M0.9270.9270.9990.886206.24M187.82M208.22M189.63M+22.69%+20.22%+18.82%+150.70%+100.91%+71.57%+82.31%--1.89%LossLoss12.20%Biotechnology
EDITEditas Medicine
3.3740.134+4.14%939.79K3.11M3.2403.2403.4103.165278.28M256.94M82.48M76.15M+6.44%+3.18%-12.59%-35.24%-36.93%-50.46%-66.69%--1.23%LossLoss7.56%Biotechnology
CRBUCaribou Biosciences
1.9750.075+3.95%631.38K1.24M1.9001.9002.0001.880178.47M160.74M90.36M81.39M+4.50%+7.92%-5.95%-14.87%-48.70%-54.39%-65.53%--0.78%LossLoss6.32%Biotechnology
APLSApellis Pharmaceuticals
27.7500.370+1.35%813.17K22.34M27.48027.38027.75027.0603.38B2.27B121.77M81.89M+1.28%+0.04%-21.90%-25.10%-44.42%-40.68%-53.64%--0.99%LossLoss2.52%Biotechnology
NTLAIntellia Therapeutics
19.6400.130+0.67%1.30M25.61M19.57019.51019.92019.3002.00B1.97B101.58M100.30M+9.78%+2.29%-12.90%-22.46%-7.23%-32.39%-35.59%--1.30%LossLoss3.18%Biotechnology
CRSPCRISPR Therapeutics
48.0250.200+0.42%629.74K30.24M47.86047.82548.54047.1954.09B4.02B85.17M83.72M+6.25%+5.36%-3.70%-14.61%-13.70%+10.00%-23.28%--0.75%LossLoss2.81%Biotechnology
AAgilent Technologies
144.5200.270+0.19%707.23K102.81M144.350144.250146.660144.06841.52B41.36B287.33M286.20M-0.06%-1.39%+4.63%+8.49%+5.48%+29.45%+4.48%0.65%0.25%30.0534.491.80%Diagnostics & Research
VRTXVertex Pharmaceuticals
483.325-1.495-0.31%860.19K415.94M487.010484.820488.000480.790124.75B124.37B258.10M257.33M+5.31%+2.89%+0.43%-2.54%+20.60%+29.40%+18.79%--0.33%Loss34.801.49%Biotechnology
BEAMBeam Therapeutics
26.310-0.280-1.05%504.22K13.38M26.60026.59026.87025.9802.17B1.79B82.42M67.87M+13.11%+12.39%+2.85%-2.74%+15.70%+18.14%-3.34%--0.74%LossLoss3.35%Biotechnology
BLUEbluebird bio
0.484-0.019-3.79%2.60M1.28M0.5000.5030.5030.48493.89M93.46M193.91M193.02M-0.62%+2.87%-3.18%-57.53%-47.53%-83.36%-64.91%--1.35%LossLoss3.87%Biotechnology

News

Comments

Read more